In the phase 3 LIBERTY study, the investigational monoclonal antibody, VYD2311, had significantly fewer adverse events than an mRNA COVID-19 vaccine, and it did not blunt vaccine-induced neutralizing titers when the two were given together.
|Articles|November 30, 2021
The Latest on Omicron
Author(s)John Parkinson
As there is a lot of information regarding the Omicron variant, here is our latest slideshow to offer some insights on it.
Advertisement
On Thanksgiving, both public health officials from South Africa and the United Kingdom gave press conferences discussing what they had learned about the new COVID-19 variant.
By the next day, the World Health Organization (WHO) had renamed it the Omicron variant, and has been giving updates on information they have obtained.
Here in the United States, President Joe Biden and his administration have been working towards reducing travel from the African countries that are thus far affected by the Omicron.
Moderna has already said it will
There is still a lot to be learned about the new variant and information is quickly being disseminated to the public to help clinicians and the general public understand what is going on.
Although there is still a lot to be learned, check out our latest slideshow to find out the latest developments.
Advertisement
Related to this article
As the Bundibugyo virus outbreak in the Democratic Republic of the Congo surpasses 9300 confirmed cases and 4400 deaths, this FAQ explains how the virus spreads, how it presents, why it is hard to diagnose and treat, which vaccines and therapies are being tested, and why CDC considers the risk to the United States low.
As of October 15, CDC reports 9235 confirmed cases and 4444 deaths in the Bundibugyo virus Ebola outbreak in the DRC, now the second-largest on record.
The latest CDC numbers show an 8.1% increase in measles cases from week-to-week, bringing the 2026 US total to 4410 confirmed cases. A CDC disease detective is going to Pennsylvania to aid in the state's massive outbreak, and the agency reports on a rare measles complication that is uniformly fatal.
Serial bloodstream isolates from two critically ill London patients showed heteroresistance, CRZ1 escape mutations, and drug-induced polyploidy despite wild-type FKS1 and susceptible MICs.
Projected disease burden from declining childhood vaccine coverage shows increases in vaccine-preventable diseases. Benjamin Lopman, PhD, provides insights on how VaxImpactMap works and the potential long-term disease consequences of decreased immunization rates.
Approximately 12% of all new cases of cancer worldwide in 2024 were attributable to an infection, with most of the infections preventable or treatable before cancer develops.
After 2 adults died of West Nile virus in central North Carolina this month, this FAQ explains how the mosquito-borne virus spreads, who faces the greatest risk of severe neuroinvasive disease, and how clinicians can diagnose, manage, and help prevent infection when no vaccine or antiviral treatment exists.
Advertisement
Advertisement